8
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of tolmetin in the treatment of active chronic rheumatoid arthritis open and controlled double-blind studies

, , , &
Pages 158-169 | Received 16 Feb 1976, Published online: 07 Aug 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sunil P. Liyanage & Christine E. Steele. (1977) Tolmetin in Osteoarthrosis of the Hip and Knee : Double-Blind Crossover Trials. Current Medical Research and Opinion 5:4, pages 299-305.
Read now
A. M. Freeman, D. N. Golding & C. E. Steele. (1977) A double-blind crossover study comparing tolmetin and indomethacin in the treatment of rheumatoid arthritis. Current Medical Research and Opinion 5:3, pages 262-265.
Read now
Mansel Aylward, F. Holly, J. Maddock & R. Wheeldon. (1977) Treatment of rheumatoid arthritis with tolmetin: A comparison with alclofenac. Current Medical Research and Opinion 4:10, pages 695-702.
Read now
Neil Cardoe & Christine E. Steele. (1977) A double-blind crossover comparison of tolmetin sodium and phenylbutazone in the treatment of rheumatoid arthritis. Current Medical Research and Opinion 4:10, pages 688-694.
Read now

Articles from other publishers (5)

Caren A. Heller, Joseph A. Ingelfinger & Peter Goldman. (1985) Nonsteroidal Antiinflammatory Drugs and Aspirin-Analyzing the Scores. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 5:1, pages 30-38.
Crossref
ANDREI CALIN. (2013) Clinical Use of Tolmetin Sodium in Patients with Ankylosing Spondylitis: A Review. The Journal of Clinical Pharmacology 23:7, pages 301-308.
Crossref
GEORGE E. EHRLICH. (2013) Long‐Term Therapy with Tolmetin in Rheumatoid Arthritis. The Journal of Clinical Pharmacology 23:7, pages 287-300.
Crossref
GEORGE E. EHRLICH. (1979) Tolmetin Sodium: Meeting the Clinical Challenge. Clinics in Rheumatic Diseases 5:2, pages 481-497.
Crossref
P. Skjelbred & P. L�kken. (1979) Paracetamol versus placebo: Effects on post-operative course. European Journal of Clinical Pharmacology 15:1, pages 27-33.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.